Atlas Trials

Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis

Clinical trial NCT05229640 · WITHDRAWN

Trial details

NCT number
NCT05229640
Sponsor
Dartmouth-Hitchcock Medical Center
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
CF - Cystic FibrosisCystic Fibrosis-related DiabetesCystic Fibrosis Liver Disease
Start date
2022-03-31
Primary completion
2023-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.